XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.

Clinical trial NCT00298623 · COMPLETED

Trial details

NCT number: NCT00298623
Sponsor: XenoPort, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2006-03-01
Primary completion: 2007-02-01
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.